Kapatia Gargi, Bhatia Prateek, Singh Minu, Jain Richa, Bansal Deepak, Gupta Kirti
Post Graduate Institute of Medical Education & Research (PGIMER), Department of Histopathology. Chandigarh, India.
Post Graduate Institute of Medical Education & Research (PGIMER), Department of Pediatrics. Chandigarh, India.
Autops Case Rep. 2020 Apr 23;10(2):e2020154. doi: 10.4322/acr.2020.154.
Langerhans cell histiocytosis (LCH), a disorder of antigen-presenting cells, is the commonest disorder of the mononuclear phagocytic system. Diagnosis is always challenging due to heterogeneous clinical presentation. However, with the evolution and better understanding of its biology, many of these children are being diagnosed early and offered appropriate therapy. Despite these advances, in developing countries, an early diagnosis is still challenging due to resource constraints for specialized tests. As a result, many patients succumb to their disease. Autopsy data on LCH is notably lacking in the literature. We sought to analyze the clinical (including mutational) and morphologic features at autopsy in six proven cases of LCH. This study includes a detailed clinico-pathological and mutational analysis of 6 proven cases of LCH. Presence of BRAF V600E mutation was assessed by both Real Time PCR and Sanger sequencing. A varied spectrum of organ involvement was noted with some rare and novel morphological findings, like nodular bronchiolocentric infiltration of LCH cells, lymphovascular emboli of LCH cells, and paucity of eosinophils within the infiltrate; these features have not been described earlier. Surprisingly, all cases were negative for BRAF V600E mutation on both RQ-PCR and Sanger sequencing. The present study is perhaps the first autopsy series on LCH. This extensive autopsy analysis represents a correlation of pathological features with clinical symptoms which provides clues for a timely diagnosis and appropriate therapeutic intervention. Also, our findings hint at the low frequency of BRAF V600E mutation in our LCH patients.
朗格汉斯细胞组织细胞增多症(LCH)是一种抗原呈递细胞疾病,是单核吞噬细胞系统最常见的疾病。由于临床表现异质性,诊断一直具有挑战性。然而,随着对其生物学的认识不断发展和深入,许多这类患儿得以早期诊断并接受适当治疗。尽管有这些进展,但在发展中国家,由于缺乏进行专门检查的资源,早期诊断仍然具有挑战性。因此,许多患者死于该病。文献中明显缺乏关于LCH的尸检数据。我们试图分析6例经证实的LCH尸检病例的临床(包括突变)和形态学特征。本研究包括对6例经证实的LCH病例进行详细的临床病理和突变分析。通过实时聚合酶链反应(Real Time PCR)和桑格测序评估BRAF V600E突变的存在情况。观察到多种器官受累情况,并发现了一些罕见和新的形态学表现,如LCH细胞的结节状支气管中心性浸润、LCH细胞的淋巴管栓子以及浸润内嗜酸性粒细胞稀少;这些特征此前尚未见描述。令人惊讶的是,所有病例在RQ-PCR和桑格测序中BRAF V600E突变均为阴性。本研究可能是首个关于LCH的尸检系列研究。这种广泛的尸检分析将病理特征与临床症状相关联,为及时诊断和适当的治疗干预提供了线索。此外,我们的研究结果提示我们的LCH患者中BRAF V600E突变的频率较低。